Kiran Sury, MD, discusses patient selection, durability, and adverse events with ProACT for male stress urinary incontinence.
Advertisement
Advertisement
Trending on Urology Times
1
Q&A: Where ProACT fits in the male stress urinary incontinence algorithm
2
CHMP recommends EU approval of belzutifan plus lenvatinib for advanced ccRCC
3
FDA grants De Novo authorization to Virtuoso Robotic System for bladder tumor resection
4
Salvage Settings, Duration, and Next Steps in Very High-Risk Prostate Cancer
5